Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

Webcast Link to Third Quarter 2023 Financial Results Conference Call on Wednesday, November 15, 2023 at 8:30 a.m. ET

Webcast Link to Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia – October 30, 2023 at 9:00 a.m. ET

Webcast Link to H.C. Wainwright 25th Annual Global Investment Conference – Tuesday. September 12, 2023

Webcast link to Second Quarter 2023 Financial Results Conference Call – Tuesday August 15, 2023 at 8:30 a.m. ET

Webcast link to H.C. Wainwright 24th Annual Global Investment Conference – Monday, September 12, 2022 at 7:00 am ET

Webcast Link to 2021 Full Year Earnings Financial Results Conference Call – Friday, March 11, 2022 at 8:30 a.m. ET

Webcast Link to Bio-Path Holdings to H.C. Wainwright Presentation – Monday, January 10, 2022 at 7:00 a.m. ET

Webcast Link Here

Webcast Link to 2021 Second Quarter Earnings Financial Results Conference Call – Friday, August 13, 2021 at 8:30 a.m. ET

Webcast Link Here

Webcast Link to 2021 First Quarter Earnings Financial Results Conference Call – Friday, May 14, 2021 at 8:30 a.m. ET

Link Here to Conference Call

Webcast Link to Third Quarter 2020 Financial Results Conference Call – Friday November 13, 2020 @ 8:30 a.m. ET

Link to Conference Call

Bio-Path Holdings

All Rights Reserved

Office:

4710 Bellaire Blvd, Suite 210
Bellaire, TX 77401

T: (832) 742-1357

R&D:

5455 Dashwood Street, Suite 300
Bellaire, TX 77401

T: (832) 742-1357

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us